Capula Management’s Elevance Health ELV Stock Holding History

Capula Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$263K	Buy	900 +500	+125%	+$164K	﹤0.01%	672
2025 Q4	$140K	Buy	400 +200	+100%	+$67.6K	﹤0.01%	661
2025 Q3	$64.6K	Sell	200 -200	-50%	-$62.2K	﹤0.01%	752
2025 Q2	$156K	Hold	400	–	–	﹤0.01%	424
2025 Q1	$174K	Buy	+400	New	+$161K	﹤0.01%	550
2023 Q1	–	Sell	-7,000	Closed	-$3.59M	–	767
2022 Q4	$3.59M	Buy	+7,000	New	+$3.55M	0.05%	291
2022 Q3	–	Sell	-3,200	Closed	-$1.54M	–	611
2022 Q2	$1.54M	Buy	+3,200	New	+$1.58M	0.03%	268
2021 Q4	–	Sell	-3,400	Closed	-$1.27M	–	388
2021 Q3	$1.27M	Sell	3,400 -8,200	-71%	-$3.12M	0.02%	489
2021 Q2	$4.43M	Sell	11,600 -7,300	-39%	-$2.79M	0.07%	209
2021 Q1	$6.78M	Buy	18,900 +11,000	+139%	+$3.54M	0.13%	171
2020 Q4	$2.54M	Buy	+7,900	New	+$2.42M	0.13%	154

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Capula Management's ELV Position: Q1 2026 in Review

Capula Management opened a new position in Elevance Health (ELV) in Q1 2026: 250 shares worth $73.2K. The stake represents ﹤0.01% of the portfolio and ranks #946 among its holdings. This is a return to the name: Capula Management previously reported a position in ELV as recently as Q3 2025.

Capula Management first reported a position in ELV in Q4 2020 and has held it in 14 quarters since. The position peaked at $2.43M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Capula Management held 250 shares of Elevance Health worth $73.2K as of Q1 2026.
Elevance Health was a new Capula Management position in Q1 2026.
Elevance Health made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #946 holding.
Capula Management first reported a position in Elevance Health in Q4 2020 and has held it in 14 quarters since.
Capula Management's Elevance Health position peaked at $2.43M in Q4 2022.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.